Kamada Ltd

KMDA XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

430M

Short interest (May 15)

0.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

4.39%

↓ 2.4%

Available Shares

800K

↑ 3.1%

Price Chart

Company Overview

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Company Info

Exchange: NASDAQ

CIK: 0001567529

Asset Type: CS

Market Data

Market Cap: $433,222,280

Employees: 462

Status: Active

Short Interest

Current Borrow Fee 4.39%

Range: 4.39% - 4.39%

Available Shares 800K

Range: 600K - 750K

Recent Changes

Fee Change: ↓ 0.1%

Available Change: ↑ 7.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime